Replies to post #78891 on Biotech Values

[DewDiligence]

Why is SPPI issuing a PR about Satraplatin now? Of what use is this information now?

It was a favor for the clinicians who had the unenviable task of presenting the Satraplatin studies at ASCO. The company may need their help again sometime.